Literature DB >> 7889013

Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia.

A Zomas1, J Mehta, R Powles, J Treleaven, T Iveson, S Singhal, B Jameson, B Paul, S Brincat, D Catovsky.   

Abstract

Unusually severe infections phenomena were observed in three patients with chronic lymphocytic leukemia (CLL) who had undergone allogeneic bone marrow transplantation (BMT) from matched sibling donors. The first developed three episodes of cytomegaloviremia requiring anti-viral therapy; the third episode accompanied by cytomegalovirus hepatitis which required prolonged therapy with foscarnet. Another had Listeria monocytogenes meningitis which was difficult to eradicate and required prolonged maintenance antimicrobial therapy with oral trimethoprim-sulfamethoxazole and intrathecal gentamicin until death due to chronic graft-versus-host disease. The third patient had cytomegaloviremia lasting 47 days, which did not clear within 4 weeks of full-dose ganciclovir. Although the number of patients is small, in our experience the problems encountered were unusually severe compared with patients allografted for other disease. We conclude that CLL patients undergoing allogeneic BMT may be at a higher risk of infectious complications than patients allografted for other diseases, and require careful monitoring.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889013

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Host resistance to Listeria monocytogenes infection is enhanced but resistance to Staphylococcus aureus infection is reduced in acute graft-versus-host disease in mice.

Authors:  T Miura; D Mizuki; S Sasaki; S Hasegawa; H Sashinami; A Nakane
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 2.  Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status.

Authors:  G Marcoullis; J Mehta; J Treleaven
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

3.  Bacterial meningitis in hematopoietic stem cell transplant recipients: a population-based prospective study.

Authors:  K E B van Veen; M C Brouwer; A van der Ende; D van de Beek
Journal:  Bone Marrow Transplant       Date:  2016-07-04       Impact factor: 5.483

4.  VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.

Authors:  Jian-Ming Li; Kasia A Darlak; Lauren Southerland; Mohammad S Hossain; David L Jaye; Cassandra D Josephson; Hilary Rosenthal; Edmund K Waller
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.